{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Mihon%20Corp.%20d%2Fb%2Fa%20VitalityVita%20and%20Boulla%2C%20LLC","name":"Mihon Corp. d/b/a VitalityVita and Boulla, LLC","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-08T18:05:58.870Z"},"count":1,"matches":[{"id":"dc75c56f86581e1e","posted_date":"2025-01-28","letter_issue_date":"2025-01-16","company_name":"Mihon Corp. d/b/a VitalityVita and Boulla, LLC","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"Unapproved New Drugs/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/dc75c56f86581e1e"}]}